Dihydroorotate Dehydrogenase Inhibitors [MoA] - N0000185501

Pharmacologic Class Information

Pharmacologic Code N0000185501
Pharmacologic Name Dihydroorotate Dehydrogenase Inhibitors
Pharmacologic Uses
  • pyrimidine synthesis inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Dihydroorotate Dehydrogenase Inhibitors

The following table contains 7 products whose active ingredient are classified under the same pharmacologic class Dihydroorotate Dehydrogenase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0115-1565Teriflunomide Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralAmneal Pharmaceuticals Of New York LlcACTIVE
58468-0210Aubagio Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralGenzyme CorporationACTIVE
58468-0211Aubagio Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralGenzyme CorporationACTIVE
69238-1303Teriflunomide Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralAmneal Pharmaceuticals Ny LlcACTIVE
69238-1304Teriflunomide Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralAmneal Pharmaceuticals Ny LlcACTIVE
69539-032Teriflunomide Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralMsn Laboratories Private LimitedACTIVE
69539-033Teriflunomide Non-Proprietary Name: TeriflunomideTablet, Film CoatedOralMsn Laboratories Private LimitedACTIVE